These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17643760)

  • 1. Healthcare use and costs of medium-chain acyl-CoA dehydrogenase deficiency in Australia: screening versus no screening.
    Haas M; Chaplin M; Joy P; Wiley V; Black C; Wilcken B
    J Pediatr; 2007 Aug; 151(2):121-6, 126.e1. PubMed ID: 17643760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands.
    van der Hilst CS; Derks TG; Reijngoud DJ; Smit GP; TenVergert EM
    J Pediatr; 2007 Aug; 151(2):115-20, 120.e1-3. PubMed ID: 17643759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal ventricular tachyarrhythmias in medium chain acyl-CoA dehydrogenase deficiency.
    Yusuf K; Jirapradittha J; Amin HJ; Yu W; Hasan SU
    Neonatology; 2010; 98(3):260-4. PubMed ID: 20414003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening.
    Hsu HW; Zytkovicz TH; Comeau AM; Strauss AW; Marsden D; Shih VE; Grady GF; Eaton RB
    Pediatrics; 2008 May; 121(5):e1108-14. PubMed ID: 18450854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medium chain acyl coenzyme A dehydrogenase (MCAD) deficiency: the case for screening all newborns.
    Alluri VN; Mulvihill JJ
    J Okla State Med Assoc; 2002 May; 95(5):326-8. PubMed ID: 12043106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Deficiency of the fatty-acid oxidising enzyme medium-chain acyl-CoA dehydrogenase (MCAD) in an adult, detected during a neonatal screening programme].
    Derks TG; Jakobs H; Gerding A; Niezen-Koning KE; Reijngoud DJ; Smit GP
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2185-90. PubMed ID: 15559414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neonatal screening for metabolic diseases: need for efficacy studies].
    Williams M
    Ned Tijdschr Geneeskd; 2008 Jul; 152(30):1653-6. PubMed ID: 18714517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infant coma in the emergency department: 2 cases of MCAD deficiency].
    Hoflack M; Caruba C; Pitelet G; Haas H; Mas JC; Paquis V; Berard E
    Arch Pediatr; 2010 Jul; 17(7):1074-7. PubMed ID: 20434892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel.
    Insinga RP; Laessig RH; Hoffman GL
    J Pediatr; 2002 Oct; 141(4):524-31. PubMed ID: 12378192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry.
    Tran K; Banerjee S; Li H; Noorani HZ; Mensinkai S; Dooley K
    Clin Biochem; 2007 Feb; 40(3-4):235-41. PubMed ID: 17222812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health services use among children diagnosed with medium-chain acyl-CoA dehydrogenase deficiency through newborn screening: a cohort study in Ontario, Canada.
    Karaceper MD; Khangura SD; Wilson K; Coyle D; Brownell M; Davies C; Dodds L; Feigenbaum A; Fell DB; Grosse SD; Guttmann A; Hawken S; Hayeems RZ; Kronick JB; Laberge AM; Little J; Mhanni A; Mitchell JJ; Nakhla M; Potter M; Prasad C; Rockman-Greenberg C; Sparkes R; Stockler S; Ueda K; Vallance H; Wilson BJ; Chakraborty P; Potter BK;
    Orphanet J Rare Dis; 2019 Mar; 14(1):70. PubMed ID: 30902101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medium-chain acyl-CoA-dehydrogenase (MCAD) deficiency: French consensus for neonatal screening, diagnosis, and management].
    Feillet F; Ogier H; Cheillan D; Aquaviva C; Labarthe F; Baruteau J; Chabrol B; de Lonlay P; Valayanopoulos V; Garnotel R; Dobbelaere D; Briand G; Jeannesson E; Vassault A; Vianey-Saban C;
    Arch Pediatr; 2012 Feb; 19(2):184-93. PubMed ID: 22244319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological functioning in children with medium chain acyl coenzyme a dehydrogenase deficiency (MCADD): the impact of early diagnosis and screening on outcome.
    Joy P; Black C; Rocca A; Haas M; Wilcken B
    Child Neuropsychol; 2009 Jan; 15(1):8-20. PubMed ID: 18608229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
    Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
    Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of the most common medium-chain acyl CoA dehydrogenase (MCAD) deficiency mutation (K329E) in the Czech newborn population.
    Kozàk L; Hrabincovà E; Rudolfoà J; Vràbelovà S; Freiberger T
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():49-50. PubMed ID: 11400780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by detecting 2-octenoyl-CoA production using high-performance liquid chromatography: a practical confirmatory test for tandem mass spectrometry newborn screening in Japan.
    Tajima G; Sakura N; Yofune H; Nishimura Y; Ono H; Hasegawa Y; Hata I; Kimura M; Yamaguchi S; Shigematsu Y; Kobayashi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):122-30. PubMed ID: 16046200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
    Hall PL; Wittenauer A; Hagar A
    Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neonatal death due to medium-chain acyl-CoA dehydrogenase deficiency: utilization of the neonatal metabolic screen in a functional approach to sudden unexplained infant death.
    Manoukian AA; Ha CE; Seaver LH; Bhagavan NV
    Am J Forensic Med Pathol; 2009 Sep; 30(3):284-6. PubMed ID: 19696588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study.
    Wilcken B; Haas M; Joy P; Wiley V; Chaplin M; Black C; Fletcher J; McGill J; Boneh A
    Lancet; 2007 Jan; 369(9555):37-42. PubMed ID: 17208640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.